$19.17+3.8%Nov 13 close
Reported results on November 13, 2026; they are not in these figures yet.
Next earnings: November 19, 2026
Figures through December 31, 2025, from the 20-F filed March 5, 2026
GH Research PLC is scheduled to report next on November 19, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending December 31, 2025, against the same quarter a year earlier.
| Measure | 3 months toDec 31, 2025 | 3 months toDec 31, 2024 | Change |
|---|---|---|---|
| Profit | -$14.1M | -$8.8M | -60.61% |
| Profit per share | -$0.23 | -$0.17 | -35.29% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
GH Research PLC reported on November 5, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Women with postpartum depression need treatments that work quickly and ask little of them at a time when they are caring for a newborn. In the Phase 2a trial, every patient was in remission within hours of a single treatment day. A single dose given in a visit of about an hour would fit the lives of new mothers, and I am glad to see GH001 move toward a pivotal program in postpartum depression,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression. GH Research PLC’s initial focus is on developing its novel and proprietary mebufotenin therapies for the treatment of patients with TRD.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K GH Research PLC filed on November 13, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.